Appointment booking for Dr. Doak Doolittle, MD is currently not available.Dr. Doak Doolittle, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Doak Doolittle, MD (he/him) is a Surgeon in Gordon, NE with over 18 years of experience. What is your opinion of Dr. Doak Doolittle, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Doak Doolittle, MD has received over $3,167 which includes payments from the following companies:
$851.00 from LifeCell Corporation
$827.02 from Davol Inc.
$270.00 from Allergan Inc.
$197.99 from Eisai Inc.
$151.89 from Pfizer Inc.
$133.45 from The Medicines Company
$124.50 from Astellas Pharma US Inc
$88.06 from Organogenesis Inc.
$83.33 from Amgen Inc.
$77.67 from Merck Sharp & Dohme Corporation
$68.65 from sanofi-aventis U.S. LLC
$66.57 from Sunovion Pharmaceuticals Inc.
$63.58 from Janssen Pharmaceuticals, Inc
$46.60 from Maquet Cardiovascular U.S. Sales, L.L.C.
$17.84 from E.R. Squibb & Sons, L.L.C.
$17.69 from Covidien Sales LLC
$16.70 from Daiichi Sankyo Inc.
$15.87 from Janssen Biotech, Inc.
$15.74 from Osiris Therapeutics Inc.
$13.89 from Boehringer Ingelheim Pharmaceuticals, Inc.
Payments received by Dr. Doak Doolittle, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!